Muscle Strength: Clinical Trials

5 trials for Muscle Strength, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Terminated 1

Follow Muscle Strength: new trials by email Literature Review of Muscle Strength trials Research Report on Muscle Strength

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure
Neprilysin, Enalapril - Heart Failure, Exercise Tolerance
Phase 4CompletedUniversity of Sao Paulo General Hospital522017-06-142020-10-22
Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers
Adductor canal block with ropivacaine 0.1% - Muscle Strength, Healthy Volunteers
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet262013-11-012014-01-10
Adductor-Canal-Blockade Versus the Femoral Nerve Block Effect on Muscle Strength and Mobilization in Healthy Volunteers
Adductor-Canal-Blockade, The femoral nerve block, Placebo - Muscle Strength, Healthy Volunteers
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet122011-10-012011-12-22
Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise
Everolimus - Disorder Related to Renal Transplantation, Exercise, Aerobic
Phase 4TerminatedJosep M Cruzado32011-09-012015-04-28
Influence of Stretching on Muscle Performance
Stretching - Muscle Strength
Phase 4CompletedFortaleza University152009-07-28

Narrower conditions

Aneurysm (1)  ·  Heart Failure (1)  ·  Motor Activity (1)

Broader conditions

Behavior (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Vascular Diseases (1)

Interventions

Angiotensin-Converting Enzyme Inhibitors (1)  ·  Enalapril (1)  ·  Everolimus (1)  ·  Neprilysin (1)  ·  sacubitril and valsartan sodium hydrate drug combination (1)

Sponsors

Copenhagen University Hospital, Rigshospitalet (2)  ·  Fortaleza University (1)  ·  Josep M Cruzado (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Brazil (2)  ·  Denmark (2)  ·  Spain (1)

Top investigators

Antonio P Barretto, PhD (1)  ·  Josep M. Cruzado, MD (1)  ·  Pia Jaeger, MD (1)

Results publications

PMID 23241723, PMID 26237001, PMID 27799178, PMID 33992607

NIH funding

2009 (1)